Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d55dd4da0d8f5bfa72abe0507617311d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2537-164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6827 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6869 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6872 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y114-11 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6827 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6872 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6869 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6806 |
filingDate |
2018-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbd401488e45b804b705ec988026ff4e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df1f6a598da24d413682e770da4a55f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c21760d4b25a3b003ee28c2a9dd74a68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7d26db9be40f4d1f20599756e105d39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bc55e6d0f3bca3721351df0f66d6aa1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0e4f19dcca6f7386add818ef77f4853 |
publicationDate |
2021-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11124825-B2 |
titleOfInvention |
Compositions and methods for analyzing modified nucleotides |
abstract |
A method for identifying any of the presence, location and phasing of modified cytosines (C) in long stretches of nucleic acids is provided. In some embodiments, the method may comprise (a) reacting a first portion of a nucleic acid sample containing at least one C and/or at least one modified C with a DNA glucosyltransferase and a cytidine deaminase to produce a first product and/or reacting a second portion of the sample with a dioxygenase, optionally a DNA glucosyltransferase and a cytidine deaminase to produce a second product and; (b) comparing the sequences from the first and optionally the second product obtained in (a), or amplification products thereof, with each other and/or an untreated reference sequence to determine which Cs in the initial nucleic acid fragment are modified. A modified TET methylcytosine dioxygenase with improved efficiency compared to unmodified TET2 at converting methylcytosine to carboxymethylcytosine is also provided. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11608518-B2 |
priorityDate |
2015-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |